Catalysts for Annora Pharma Pvt Ltd
6 tracked
Mar 25, 2026
recall
Annora Pharma Private Limited recall (Cls III)
Annora Pharma Pvt Ltd
→
Mar 18, 2026
approval
DESOGESTREL AND ETHINYL ESTRADIOL (DESOGESTREL) — FDA approval
DESOGESTREL AND ETHINYL ESTRADIOL
→
Mar 5, 2026
approval
PAROXETINE HYDROCHLORIDE — FDA approval
PAROXETINE HYDROCHLORIDE
→
Oct 2, 2025
approval
MIRTAZAPINE — FDA approval
mirtazapine ODT
→
Oct 1, 2025
approval
BUPROPION HYDROCHLORIDE — FDA approval
BUPROPION HYDROCHLORIDE
→
Sep 30, 2025
approval
LEVONORGESTREL — FDA approval
Postinor
→